Roberta Ciampichini

Suggest Changes
Learn More
OBJECTIVES Poor information on long-term outcomes and costs on tumour necrosis factor (TNF) inhibitors in psoriatic arthritis (PsA) are available. Our aim was to evaluate long-term costs and benefits(More)